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1. Intr~uction 
The response of cells and tissues to hormones and 
other regulatory molecules is regulated not only by 
the availability of the ligand but also by a modulation 
of the tissue’s responsiveness. 
In most cases, including the @adrenergic stimulation 
of skin [ 11, temporary subsensitivity (tachyphylaxis) 
is the response to an excessive stimulation which 
otherwise would lead to regulatory paralysis [2], It 
appears that such an adaptive reaction can be due to 
several different mechanisms [2] such as a conforma- 
tional change of the receptor protein, so that it cannot 
transfer the hormonal signal; ‘internalization’ of 
membrane-bound hormone-receptor complexes and 
subsequent lysosomal degradation in the course of an 
endocytotic process (down regulation); or an activa- 
tion of enzymes which destroy the hormone itself or 
its second messenger, for example cyclic AMP phos- 
phodiesterase. In addition, some evidence exists that 
/3-adrenergic stimulation may give rise to the de-novo 
synthesis of a short-lived ‘refractoriness protein’ in 
the target cell which somehow decreases hormone 
res~nsiveness 131. The latter process seems to be 
especially interesting since it indicates the existence 
of a specific and sophisticated regulatory mechanism. 
As yet, however, it has been demonstrated only with 
a special tumor cell line in vitro so that its physiological 
role might be questionable. Here I show that a similar 
or even identical mechanism exists in a normal tissue 
in the living animal, i.e. in mouse epidermis. 
2. Materials and methods 
D,L-Isoproterenol(IPR,isoprenaline) wasobtained 
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from Serva (Heidelberg) and l-methyl-3.isobutyl- 
xanthine (MIX) from Aldrich Ega-Chemie. Labelled 
compounds were purchased from Amersham-Buchler 
(Braunschweig). 
Female NMRI-mice (age 7-8 weeks) whose backs 
had been shaved 4 days earlier [8f were used in all 
experiments. 
For determination of cyclic AMP in epidermis the 
animals were killed by cervical dislocation and the 
skin of the back was immediately snap-frozen at 
-80°C. Then the epidermis was scraped off by means 
of a pre-cooled scalpel and ~mediately homogenized 
in 1.5 ml 3% trichloroacetic acid. Cyclic AMP was 
isolated from the supernatant as described [4,8] and 
assayed by means of a commercially available assay 
kit (Amersham-Buchler, Braunschweig). For deter- 
mination of DNA see [8f. Under the conditions 
described no artifactual increase of epidermal cyclic 
AMP (for example due to ischaemia) was observed. 
For determination of protein labelling in epidermis 
the animals received an i.p. injection of 100 &i [3H]- 
amino acid mixture 1 h before they were killed. The 
epidermis was scraped off as described above and 
homogenized in 2 ml 0.5 M perchloric acid (PCA). 
After centrifugation the sediment was washed three 
times with cold 0.2 M PCA (% 4 ml), suspended in 
2 ml 0.5 PCA and heated in a boiling water bath for 
10 min. After centrifugation the sediment was washed 
twice with 2 ml 0.5 M PCA, once with 4 ml ethanol and 
dried. The residue was suspended in 2.5 ml 0.5 M NaOH, 
heated at 80°C for 30 min and centrifuged. Then the 
clear supernatant wasused for determination of radio- 
activity and protein assay according to the Lowry 
procedure. 
The activity of epidermal adenylate cyclase was 
determined in epidermis homogenate in the presence 
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of 3 mM MnClz [IO] using the pooled homogenates 
of 2 mice (in 2 ml buffer) and [cx-~~P]ATP as a sub- 
strate [lo]. The activity of cyclic AMP phosphodi- 
esterase was assayed [9] using the pooled homogenates 
of 2 mice (in 4 ml buffer) and 20 PM [‘HIcyclic AMP 
as a substrate (high affinity conditions f9]). 
3. Results 
A single i.p. injection of IPR caused alo- to ZO-fold 
increase of the level of cyclic AMP in dorsal mouse 
epidermis within 2.5 min (see also [4]). Between 7 
and 10 min the cyclic AMP content began to decline 
almost reaching control levels after 20 mm (fig.1). A 
maximal response was achieved with 0.25 mg IPR 
(40 ~mol/kg) d an no further increase of cyclic AMP 
production was observed when the IPRdose was 
raised to 1 mg (fig.1). Using tritium-labelled IPR the 
elevation of cyclic AMP content was found not to 
coincide with the distribution of radioacti~ty in 
epidermis in that the former was already terminated 
before the latter had reached its maximal value. Under 
the assumption that the radioactivity measured was 
mainly due to isoproterenol instead of to breakdown 
products, this observation may be taken as an indica- 
tion that a catecholamine r fractoriness of epidermal 
cyclic AMP production had developed shortly after 
treatment. 
Indeed, when a second injection of IPR was given 
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Fig.1. Effect of D,L-isoproterenol (IPR) on cycIic AMP accumuiation in dorsal mouse epidermis ln viva. (a) Tie course of cyclic 
AMP accumulation after i.p. injection of either 0.25 mg (black circles, solid line; each point represents the mean of 6 or more 
experiments (animals) *SD.) or 1 .OO mg IPR (open circles, broken line; each point represents an experiment with one animal). As 
indicated by the arrow, a second injection of 0.25 mg IPR was given 90 min after the fast injection. The dotted line (black triangles) 
shows the distribution of radioactivity in epidermis after i.p. injection of 0.1 mg [%‘H]lPR (0.2 PCi). For determination of radio- 
activity the epidermis was dissolved in 1 ml soluene (60 ntin, 60°C). Each point represents one animal. (b) Accumu~tion of cyclic 
AMP, measured 7 mm after a second injection of 0.25 mg IPR at 90 mm, as a function of the initiaf IPR dose (injected at zero 
time). The insert shows the effect of a second injection of 0.25 mg IPR on cyclic AMP production, measured after 7 min as a func- 
tion of the time interval between fust and second injection (0.25 mg IPR given at zero time; n 2 4, *S.D.). 
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90 min after the initial treatment the accumulation of
cyclic AMP was found to be greatly dinl~ished (fig.1). 
The degree of inhibition depended on the initial IPR 
dose rather than on the amount of cyclic AMP initially 
generated. Refractoriness could already be observed 
20 min after the first injection and lasted for several 
hours (f&l). 
The accunlulation of cyclic AMP in epidermis 
could be considerably prolonged when cycloheximide 
was i.p. injected 15 min prior to isoproterenoi (fig.2). 
When a rechallenge with IPR was made 90 min after 
the first treatment no refractoriness of cyclic AMP 
production could be observed in cyclohexim~de-treated 
animals (fig.2). Azacytidine, which has been shown to 
prevent in epidermis events due to RNA biosynthesis 
[5], did not show such an effect. 
The accumulation of cyclic AMP in epidermis 
could also be prolonged when the animals were treated 
with MIX, a powerful inhibitor of cyclic AMP phos- 
phodiesterase, prior to IPR injection (fig.2). There- 
fore, the refractoriness could perhaps be due to an 
increased activity of this enzyme in IPR-treated skin. 
This possibility was, however, ruled out because no 
increased phosphodiesterase ctivity was observed in 
0 
- 40 - 6-O - 80 100 - MIX 
min. 
Fig.%. Effect of cycloheximide and 1-methyl-3-isobutyl xanthine (MIX) on IPR-induced accumulation of cyclic AMP in dorsal 
mouse epidermis in vivo. The animals were injected i.p. twice with 0.25 mg IPR each at zero time and 90 min later (arrow). 
(a) Black circles, solid line: control animals (see fig.1). Open circles, broken line: 5 mg cycloheximide were injected i.p. IS mirr 
prior to the firsi IPR treatment. Black circles, dotted line: 1.5 mg MIX (dissolved in acetoneethanol) was topically applied 40 min 
prior and 1 mg MIX injected i.p. 5 mm prior to the first IPR treatment. Black triangles, dotted line, the animals were treated with 
MIX as described above prior to the second IPR injection. For further details see fig.1. (b) Effect of four injections of either NaCI- 
solution (controls: open columns) or 0.25 mg IPR each (hatched columns) given at 0,30 and 60 and 90 min on the accumu~tion 
of cyclic AMP as measured 7 min after the fourth injection (circles: no pre-treatment; riangles: treatment with MIX as described 
above prior to the fotrrth IPR injection). Each point represents one animal. The insert shows the effect of cycloheximide on pro- 
tein labeling in mouse epidermis in vivo. 0.9% NaCl solution (controls) or cycloheximide (5 mg) was injected at zero time and the 
animals were killed at the times indicated, 1 h prior to killing 100 &i [‘Hfamino acid mixture (Amersham-Buchler) was injected 
i.p. Each point represents the mean value of 5 or more experiments (animals) +-S.D. Ordinate, cpm per mg protein expressed in % 
of the control. 
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epidermal homogenates made from IPR-treated ani- 
mals as compared with control mice, and pretreatment 
of the animals with cycloheximide did not show any 
effect on phosphodiesterase activity either in control 
or in IPR-treated mice (table 1). Furthermore, under 
conditions (50 /.&I Ca’+) which have been shown to 
lead to a maximal activation of the calcium-dependent 
regulator protein (CDR) of PDE [6] no difference 
could be seen between IPR-treated and control ani- 
mals thus ruling out the possibility that CDR rather 
than PDE was activated (table 1). Finally, refracto- 
riness could not be overcome by an excessive dose of 
MIX administered prior to the last IPR injection. As 
shown in fig.2 an increase of cyclic AMP level of 
only 150-200% was observed, which occurs also in 
control animals. As shown in table 1 there was also 
no difference in basal or fluoride-stimulated adenylate 
cyclase activity in epidermal homogenates of IPR- 
treated animals as compared with control mice. 
Table 1 
Activities of adenylate cyclase (AC) and cyclic AMP-phosphodiesterase (PDE) in epidermal homogenates 
from control and IPR-treated mice 
Enzyme Assay IPR Enzyme activity (cpm/min per mg protein) 
conditions dose 
(mg) Control IPR-treated 
Exp. I II III Exp. I II III 
AC normal 1 510 904 532 598 899 502 
AC 50 mM NaF 1 1897 2870 2756 2702 3462 2765 
PDE normal 0.25 1266 f 133 1431 * 202 
PDE 50 PM CaCI, 0.25 1303 f 235 1233 f 167 
PDE normal 1 1898 + 267 1067 + 159 
PDE normala 0.25 2065 + 231 1704 f 198 
a 5 mg cycloheximide were i.p. injected 15 min prior to IPR-injection 
The animals were injected with either 0.9% NaCl solution (controls) or DL-isoproterenol90 min prior to 
killing as described in fig.1. For phosphodiesterase mean values of 5 assays (rS.D.) are given 
4. Discussion 
The results show that a cycloheximide-sensitive 
desensitization of p-adrenergic yclic AMP production 
which has been recently observed with C6-2B astro- 
cytoma cells in vitro [3] can also occur in mouse 
epidermis in vivo. Therefore, this autoregulatory pro- 
cess may be considered to be physiologically significant 
To explain the cycloheximide-sensitivity a ‘refrac- 
toriness protein’ with a high turnover rate has been 
postulated. This protein was assumed to inhibit the 
interaction of the hormone-receptor complex with 
adenylate cyclase without reducing the number of 
receptor molecules [3]. Due to technical difficulties 
a reliable determination of the receptor content of 
mouse epidermis in vivo has not yet been achieved. 
Nevertheless, a similar interpretation might be appli- 
cable for the observations described here, especially 
since neither an activation of cyclic AMP phosphodi- 
esterase nor an inactivation of adenylate cyclase was 
observed in subsensitive mouse epidermis and because 
it is well known that endocytotic down regulation of 
receptor sites doesnot depend on protein synthesis [2]. 
The time course of the events indicates that the 
synthesis of putative refractoriness protein starts 
shortly after catecholamine injection. Thus, by using 
this mechanism the cell is able not only to adapt to 
subsequent hormonal challenge but, in addition, to 
terminate - together with cyclic AMP-PDE - even 
the response to the initial stimulation. This seems to 
be especially remarkable since in most cases studied 
thus far a, prolonged exposure to the hormone was 
necessary to achieve significant subsensitivity. 
It is not clear whether or not cyclic AMP is involved 
in the synthesis of the inhibitor. After all, a clear-cut 
correlation between cyclic AMP level and subsequent 
desensitization was not observed, and comparing the 
temperature sensitivity of cyclic AMP production 
with that of refractoriness in C6-2B astrocytoma cells 
Nickels and Brooker [7] also came to the conclusion 
that cyclic AMP is not directly involved in the devel- 
opment of refractoriness. 
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